One of the bigger challenges, both in terms of numbers of infections and difficulty in developing a vaccine, is malaria. A variety of malaria vaccine approaches have been proposed and developed. The best result to date was a finding of 55% efficacy in a large scale trial, meaning vaccinated individuals were a little less than half as likely to become infected. Now, a new study of a different vaccine demonstrated 77% efficacy in a moderate scale test, comparable to a phase II trial.
Over the past weeks, the Emerging Scholars Network has been addressing the concerns a number of people have about receiving one of the COVID-19 vaccines. Our previous posts have included an article provided by the Centers for Disease Control and two posts (Immunization is a Team Sport and Slowing Down to Build Trust) by our […]
The votes are in, the bracket is complete, and we have a most pressing science & faith question: How much should science inform religious practice? If I thought my seedings had any meaning, this would be a Cinderella story, the lowest seed in the Theology & Religion going on to take it all. Now that […]
Many of us have struggled talking with family or friends who are hesitant to be vaccinated for COVID-19. A friend of ESN from the Centers for Disease Control and Prevention (CDC) approached us about posting an article from the CDC with helpful ideas for these difficult conversations. We are delighted to share this article, written […]
I left out pandemic topics in part because I wanted this series to provide some respite from them and in part because their urgency is only temporary. Still, public health remains my vocation and so my thoughts never stray too far from SARS-CoV-2. That also means I am extra motivated to do what I can to bring about a time when I can put my focus elsewhere.